Clinical Analysis & Further Management

Putting the Picture Together

• Berek & Novak's Gynecology, p. 578: "Homogeneous hemorrhagic-appearing cysts that fail to resolve after one to two menstrual cycles are suspicious for endometriomas."

Step 1: Investigations (Workup)

• Has the cyst persisted, grown, or changed character?
• Classic endometrioma appearance: ground-glass echogenicity, homogeneous low-level internal echoes, no papillary projections
• Document cyst size (>3 cm is clinically significant)

• CA-125: Elevated in endometriosis (non-specific but useful for monitoring; also helps rule out malignancy in context)
• CBC, LFTs (vomiting severity)
• Hormonal panel for irregular cycles: Day 2-3 FSH, LH, Estradiol, AMH, Prolactin, TSH, fasting insulin, testosterone, DHEAS (to rule out PCOS/thyroid/hyperprolactinemia as cause of irregular cycles)

• Better characterization of deep infiltrating endometriosis, rectovaginal lesions, adenomyosis

Step 2: Confirm the Likely Diagnosis

• No adnexal mass requiring urgent excision
• Patient is not actively trying to conceive
• Presentation is typical for endometriosis
• Berek & Novak's Gynecology, p. 578: "An expert consensus panel recommended that women with suspected endometriosis who are not actively trying to conceive and who do not have an adnexal mass start with first-line medical management before laparoscopy."

Step 3: Management Plan

First-line Medical (Pharmacologic) Treatment

1. NSAIDs (e.g., Mefenamic acid 500 mg TDS or Naproxen 500 mg BD)
   • Start 2-3 days before expected menses; continue for 3-5 days
   • Reduces prostaglandin-mediated pain and vomiting
   • Address the vomiting with antiemetics (Ondansetron, Metoclopramide) if needed
2. Combined Oral Contraceptive Pill (OCP)
   • First-line hormonal therapy for secondary dysmenorrhea from endometriosis
   • Can be given cyclically or continuously (continuous OCP reduces bleeding frequency and may be more effective for pain)
   • Both cyclic and continuous formulations have equal efficacy; continuous regimens or those using newer-generation progestins preferred for refractory symptoms
   • Also helps regulate the irregular menstrual cycles
3. Progestins (second-line) - if OCP fails or estrogen is contraindicated
   • Medroxyprogesterone acetate (high dose), Norethindrone acetate, Dienogest
   • Given at a dose that achieves amenorrhea, then tapered
   • Effective in ~75% of women with endometriosis
4. Levonorgestrel IUS (Mirena)
   • Equally effective as depot GnRH agonist for endometriosis-related chronic pain
   • Good option if ongoing contraception desired
5. GnRH Agonists (Leuprolide, Triptorelin) - second-line
   • Used for 6 months; causes hypogonadotropic amenorrhea
   • Add-back therapy (low-dose estrogen + progestin) is mandatory to prevent bone loss and vasomotor symptoms
   • Reserved for refractory cases or pre-surgical preparation

Management of the Ovarian Cyst

• If cyst is < 4 cm: Medical management and watchful waiting with repeat USG in 6-8 weeks is appropriate
• If cyst is > 4 cm or persistent/growing: Surgical management is recommended
  • Laparoscopic ovarian cystectomy (preferred) - excise the cyst capsule completely; do NOT just drain/coagulate
  • Berek & Novak's Gynecology, p. 580: "Resection of endometriomas by ovarian cystectomy improves pain and fertility in women with CPP and endometriosis when compared to fenestration, drainage, and coagulation."
  • Histological confirmation is mandatory - to distinguish endometrioma from hemorrhagic corpus luteum or neoplasm

Managing Irregular Cycles

• Once hormonal workup is complete, address the underlying cause (PCOS, thyroid, hyperprolactinemia)
• OCPs serve double duty here - treating dysmenorrhea AND regulating cycles

Step 4: Surgical Management (When Indicated)

• Cyst persists or is > 4 cm on repeat USG
• Failure of 3-6 months of medical therapy
• Desire for fertility (laparoscopy before ART is debated but often done for large endometriomas)
• Uncertainty about diagnosis

• Inspect peritoneum, ovaries, cul-de-sac, uterosacral ligaments
• Ablate or excise all visible endometriotic implants
• Perform ovarian cystectomy (not just drainage)
• Biopsy suspicious lesions for histological confirmation

Step 5: Counseling Points

• Fertility: Discuss early, even if not currently planning pregnancy - endometriosis can impair ovarian reserve. The right ovarian cyst needs careful surgical technique to preserve ovarian tissue. An AMH level should be checked.
• Recurrence: Pain recurs in ~50% at 24 months after surgery; long-term post-operative OCP or progestin use reduces recurrence
• Lifestyle: Anti-inflammatory diet may help (recent meta-analysis supports dietary interventions for endometriosis-related pain - PMID 39358652)
• Mental health: Chronic pain disorders have significant psychological burden; screen and refer if needed

Summary Algorithm

Repeat TVS in 6-8 weeks
        |
        +-- Cyst resolving + symptoms manageable
        |        → Continue OCP + NSAIDs, monitor
        |
        +-- Cyst persistent >4 cm OR symptoms refractory
                 → Diagnostic + Operative Laparoscopy
                     (Cystectomy + lesion ablation + biopsy)

Recent evidence note (PMID 40373315, 2025 Network Meta-Analysis, Obstet Gynecol): A 2025 systematic review and network meta-analysis on pharmacologic interventions for endometriosis-related pain confirmed that GnRH agonists, combined OCPs, and progestins all remain effective; no major change to first-line OCP + NSAID recommendations.